Open AccessThe Cardiopulmonary Effects of the Calcitonin Generelated Peptide Family
Author(s) -
Gökçen Telli,
Banu Cahide Tel,
Bülent Gümüşel
Publication year - 2020
Publication title -
turkish journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.241
H-Index - 14
eISSN - 2148-6247
pISSN - 1304-530X
DOI - 10.4274/tjps.galenos.2019.47123
Subject(s) - adrenomedullin , calcitonin gene related peptide , calcitonin , medicine , cardiopulmonary bypass , population , bioinformatics , intensive care medicine , biology , receptor , neuropeptide , environmental health
Cardiopulmonary diseases are very common among the population. They are high-cost diseases and there are still no definitive treatments. The roles of members of the calcitonin-gene related-peptide (CGRP) family in treating cardiopulmonary diseases have been studied for many years and promising results obtained. Especially in recent years, two important members of the family, adrenomedullin and adrenomedullin2/intermedin, have been considered new treatment targets in cardiopulmonary diseases. In this review, the roles of CGRP family members in cardiopulmonary diseases are investigated based on the studies performed to date.